West Pharmaceutical Services Inc (WST)
360.43
-7.75
(-2.10%)
USD |
NYSE |
Apr 26, 16:00
360.24
-0.18
(-0.05%)
Pre-Market: 20:00
West Pharmaceutical Services Research and Development Expense (Quarterly): 17.60M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 17.60M |
| December 31, 2023 | 18.40M |
| September 30, 2023 | 16.40M |
| June 30, 2023 | 16.50M |
| March 31, 2023 | 17.10M |
| December 31, 2022 | 15.90M |
| September 30, 2022 | 13.60M |
| June 30, 2022 | 14.40M |
| March 31, 2022 | 14.60M |
| December 31, 2021 | 13.70M |
| September 30, 2021 | 13.10M |
| June 30, 2021 | 13.80M |
| March 31, 2021 | 12.20M |
| December 31, 2020 | 12.90M |
| September 30, 2020 | 12.50M |
| June 30, 2020 | 10.80M |
| March 31, 2020 | 10.70M |
| December 31, 2019 | 10.20M |
| September 30, 2019 | 9.30M |
| June 30, 2019 | 9.60M |
| March 31, 2019 | 9.80M |
| December 31, 2018 | 9.80M |
| September 30, 2018 | 10.10M |
| June 30, 2018 | 10.80M |
| March 31, 2018 | 9.60M |
| Date | Value |
|---|---|
| December 31, 2017 | 9.70M |
| September 30, 2017 | 9.10M |
| June 30, 2017 | 10.00M |
| March 31, 2017 | 10.30M |
| December 31, 2016 | 9.60M |
| September 30, 2016 | 9.00M |
| June 30, 2016 | 8.80M |
| March 31, 2016 | 9.40M |
| December 31, 2015 | 10.00M |
| September 30, 2015 | 8.50M |
| June 30, 2015 | 8.10M |
| March 31, 2015 | 7.50M |
| December 31, 2014 | 7.80M |
| September 30, 2014 | 10.80M |
| June 30, 2014 | 9.90M |
| March 31, 2014 | 10.00M |
| December 31, 2013 | 9.70M |
| September 30, 2013 | 9.60M |
| June 30, 2013 | 9.50M |
| March 31, 2013 | 9.10M |
| December 31, 2012 | 8.60M |
| September 30, 2012 | 8.20M |
| June 30, 2012 | 8.20M |
| March 31, 2012 | 8.30M |
| December 31, 2011 | 7.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.30M
Minimum
Sep 2019
18.40M
Maximum
Dec 2023
13.66M
Average
13.65M
Median
Research and Development Expense (Quarterly) Benchmarks
| Becton Dickinson & Co | 290.00M |
| Abbott Laboratories | 684.00M |
| Masimo Corp | 38.00M |
| Merit Medical Systems Inc | 21.64M |
| Insulet Corp | 42.00M |